Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$2.72B |
| 2 |
Meta Platforms (Facebook)
META
|
+$660M |
| 3 |
Micron Technology
MU
|
+$605M |
| 4 |
Mastercard
MA
|
+$497M |
| 5 |
Tesla
TSLA
|
+$495M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.33B |
| 2 |
Visa
V
|
+$1.26B |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.23B |
| 4 |
Lam Research
LRCX
|
+$699M |
| 5 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$681M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 79.37% |
| 2 | Technology | 4.49% |
| 3 | Healthcare | 2.99% |
| 4 | Financials | 2.85% |
| 5 | Industrials | 2.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
10351
PUT
Genius Sports
GENI
$1.6B
| $310K | ﹤0.01% |
70,000
-14,900
| -18% | -$106K |
2021 Q2
19 quarters
|
|
10352
C&F Financial
CFFI
$323M
| $310K | ﹤0.01% |
4,250
-5,273
| -55% | -$388K |
2025 Q2
3 quarters
|
|
|
CRWG
10353
CALL
Leverage Shares 2X Long CRWV Daily ETF
CRWG
$117M
| $310K | ﹤0.01% |
13,070
-3,110
| -19% | -$110K |
2025 Q3
2 quarters
|
|
10354
CALL
Encompass Health
EHC
$11.9B
| $310K | ﹤0.01% |
3,200
-4,400
| -58% | -$451K |
2017 Q1
36 quarters
|
|
10355
CALL
Veralto
VLTO
$23.5B
| $309K | ﹤0.01% |
3,500
-6,519
| -65% | -$620K |
2023 Q4
9 quarters
|
|
10356
CALL
Casella Waste Systems
CWST
$5.31B
| $309K | ﹤0.01% |
3,900
-7,300
| -65% | -$699K |
2021 Q1
20 quarters
|
|
10357
Quadratic Interest Rate Volatility and Inflation Hedge ETF
IVOL
$243M
| $309K | ﹤0.01% |
16,536
-50,226
| -75% | -$949K |
2023 Q4
9 quarters
|
|
10358
CALL
Ironwood Pharmaceuticals
IRWD
$603M
| $309K | ﹤0.01% |
88,100
-46,000
| -34% | -$189K |
2022 Q4
13 quarters
|
|
10359
CALL
Viant Technology
DSP
$257M
| $309K | ﹤0.01% |
27,600
+6,800
| +33% | +$75.2K |
2021 Q3
18 quarters
|
|
10360
Inseego
INSG
$81.2M
| $309K | ﹤0.01% |
+27,797
| New | +$313K |
2026 Q1
0 quarters
|
|
10361
John Hancock Mortgage-Backed Securities ETF
JHMB
$210M
| $309K | ﹤0.01% |
+14,040
| New | +$312K |
2026 Q1
0 quarters
|
|
|
ZFEB
10362
Innovator Equity Defined Protection ETF - 1 Yr February
ZFEB
$151M
| $309K | ﹤0.01% |
+12,170
| New | +$310K |
2026 Q1
0 quarters
|
|
|
TSMG
10363
PUT
Leverage Shares 2X Long TSM Daily ETF
TSMG
$40.5M
| $309K | ﹤0.01% |
+11,200
| New | +$331K |
2026 Q1
0 quarters
|
|
|
CGUI
10364
Capital Group Ultra Short Income ETF
CGUI
$338M
| $309K | ﹤0.01% |
12,219
-30,888
| -72% | -$783K |
2025 Q3
2 quarters
|
|
10365
CALL
Gogo Inc
GOGO
$290M
| $309K | ﹤0.01% |
76,800
-15,800
| -17% | -$72K |
2013 Q4
49 quarters
|
|
10366
CALL
Vanguard Intermediate-Term Bond ETF
BIV
$27.9B
| $309K | ﹤0.01% |
4,000
+1,200
| +43% | +$93.4K |
2025 Q3
2 quarters
|
|
|
AVGW
10367
CALL
Roundhill AVGO WeeklyPay ETF
AVGW
$43.6M
| $308K | ﹤0.01% |
8,500
+300
| +4% | +$12.5K |
2025 Q4
1 quarter
|
|
10368
SB Financial Group
SBFG
$181M
| $308K | ﹤0.01% |
14,675
-289
| -2% | -$6.13K |
2025 Q1
4 quarters
|
|
10369
Sound Equity Dividend Income ETF
DIVY
$27.8M
| $308K | ﹤0.01% |
+11,207
| New | +$311K |
2026 Q1
0 quarters
|
|
10370
PUT
Editas Medicine
EDIT
$428M
| $308K | ﹤0.01% |
124,600
+57,000
| +84% | +$121K |
2017 Q1
36 quarters
|
|
|
INGM
10371
CALL
Ingram Micro Holding
INGM
$6.34B
| $308K | ﹤0.01% |
+13,200
| New | +$287K |
2026 Q1
0 quarters
|
|
|
YARW
10372
Yarrow Bioscience
YARW
$171M
| $307K | ﹤0.01% |
10,289
+9,678
| +1,584% | +$282K |
2025 Q4
1 quarter
|
|
10373
MaxLinear
MXL
$9.57B
| $307K | ﹤0.01% |
17,660
-11,867
| -40% | -$213K |
2021 Q3
18 quarters
|
|
10374
PUT
Castle Biosciences
CSTL
$1.12B
| $307K | ﹤0.01% |
+12,500
| New | +$409K |
2026 Q1
0 quarters
|
|
|
BANX
10375
CALL
ArrowMark Financial
BANX
$195M
| $307K | ﹤0.01% |
16,100
+3,900
| +32% | +$79K |
2025 Q4
1 quarter
|
|
Similar funds
Citadel Advisors's Q1 2026 Portfolio in Review
As of Q1 2026, Citadel Advisors held 14,860 positions worth $618B, down 7.1% from $666B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Citadel Advisors's Q1 2026 filing shows 2,347 new, 5,138 increased, 5,286 reduced and 2,003 closed positions. Its largest new stake was iShares 7-10 Year Treasury Bond ETF: 3,431,225 shares worth $327M. The largest sale was Amazon, an estimated $1.33B.
By sector, the portfolio is most concentrated in Miscellaneous at 79% of assets, down from 80% a quarter earlier, followed by Technology and Healthcare.
- Citadel Advisors's largest Q1 2026 buy was iShares 7-10 Year Treasury Bond ETF: 3,431,225 shares worth $327M.
- Citadel Advisors added most to iShares Core S&P 500 ETF in Q1 2026, an estimated $2.72B increase.
- Citadel Advisors's biggest Q1 2026 reduction was Amazon, cutting an estimated $1.33B.
- Citadel Advisors fully exited CyberArk in Q1 2026, selling an estimated $305M.
- Citadel Advisors's ten largest holdings make up 22% of its $618B portfolio in Q1 2026.
- Citadel Advisors opened 2,347 new positions and closed 2,003 in Q1 2026.
- Citadel Advisors's portfolio value fell 7.1% quarter-over-quarter to $618B.
Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.